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Abstract 
Background: The blood–cerebrospinal fluid barrier (BCSFB) established by the choroid plexus (CP) epithelium has 
been recognized as a potential entry site of immune cells into the central nervous system during immunosurveillance 
and neuroinflammation. The location of the choroid plexus impedes in vivo analysis of immune cell trafficking across 
the BCSFB. Thus, research on cellular and molecular mechanisms of immune cell migration across the BCSFB is largely 
limited to in vitro models. In addition to forming contact-inhibited epithelial monolayers that express adhesion mole-
cules, the optimal in vitro model must establish a tight permeability barrier as this influences immune cell diapedesis.
Methods: We compared cell line models of the mouse BCSFB derived from the Immortomouse® and the ECPC4 line 
to primary mouse choroid plexus epithelial cell (pmCPEC) cultures for their ability to establish differentiated and tight 
in vitro models of the BCSFB.
Results: We found that inducible cell line models established from the Immortomouse® or the ECPC4 tumor cell 
line did not express characteristic epithelial proteins such as cytokeratin and E-cadherin and failed to reproducibly 
establish contact-inhibited epithelial monolayers that formed a tight permeability barrier. In contrast, cultures of 
highly-purified pmCPECs expressed cytokeratin and displayed mature BCSFB characteristic junctional complexes as 
visualized by the junctional localization of E-cadherin, β-catenin and claudins-1, -2, -3 and -11. pmCPECs formed a 
tight barrier with low permeability and high electrical resistance. When grown in inverted filter cultures, pmCPECs 
were suitable to study T cell migration from the basolateral to the apical side of the BCSFB, thus correctly modelling 
in vivo migration of immune cells from the blood to the CSF.
Conclusions: Our study excludes inducible and tumor cell line mouse models as suitable to study immune functions 
of the BCSFB in vitro. Rather, we introduce here an in vitro inverted filter model of the primary mouse BCSFB suited to 
study the cellular and molecular mechanisms mediating immune cell migration across the BCSFB during immunosur-
veillance and neuroinflammation.
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Background
The choroid plexus (CP) is a highly-vascularized struc-
ture that folds from the ependymal lining of the lateral, 
third and fourth ventricles in a convoluted fashion into 
cerebrospinal fluid (CSF)-filled ventricular spaces. In 
contrast to brain microvessels at the blood–brain bar-
rier (BBB), CP microvessels are fenestrated and allow for 
free diffusion of molecules from the blood into the CP 
stroma. Highly-polarized epithelial cells, which cover 
the entire surface of the CP, establish a barrier between 
the blood and the CSF, the blood–cerebrospinal fluid 
barrier (BCSFB). While preventing the free diffusion of 
blood components into CSF, the BCSFB regulates the 
transport of metabolites and is considered the major 
source of the CSF (reviewed in [1, 2]). Paracellular diffu-
sion of molecules is prevented by unique tight junctions 
(TJs) constituted by the oligodendrocyte specific protein 
(OSP/claudin-11) that runs in parallel strands around the 
entire circumference of the CP epithelial cells [2, 3]. In 
addition to claudin-11, BCSFB TJs are composed of clau-
din-1, -2 and -3, occludin, and junctional adhesion mol-
ecules A and B (JAM-A and JAM-B), while the zonula 
occludens-1, 2, 3 (ZO1, 2, 3) scaffolding proteins connect 
BCSFB TJ proteins to the actin cytoskeleton (summa-
rized in [4]). The adherens junctions (AJ) of the BCSFB 
are formed by homophilic interactions of the transmem-
brane epithelial cadherin (E-cadherin) that is linked to 
the actin cytoskeleton via α- and β-catenin [5, 6].
Over the last decades, evidence has accumulated for a 
potential role of the choroid plexus, and thus specifically 
the BCSFB, in controlling immune cell entry into the 
CNS. It has been shown that during experimental auto-
immune encephalomyelitis (EAE), an animal model for 
multiple sclerosis (MS), functional expression of inter-
cellular adhesion molecule (ICAM)-1 and vascular cell 
adhesion molecule (VCAM)-1 is upregulated on choroid 
plexus epithelial cells [3, 7, 8]. ICAM-1 and VCAM-1 
mediate the migration of circulating autoaggressive T 
cells across the endothelial BBB in EAE (summarized in 
[9]) and have been suggested to also play a role in medi-
ating immune cell trafficking across the BCSFB [10]. In 
addition, the recent observations that CCR6-deficient 
mice are resistant to EAE and that CCL20 is expressed by 
CP epithelial cells but not by the endothelial cells forming 
the BBB [11], support a role for the chemokine receptor 
CCR6 and its ligand CCL20 in mediating the migration 
of neuroantigen-specific CD4+ Th17 cells into the CNS. 
Last but not least, the CP mediates neutrophil invasion 
into the CNS after traumatic brain injury [12] and in bac-
terial and viral infections [13].
Beyond these observations, our knowledge on the cel-
lular and molecular mechanisms involved in immune cell 
migration across the BCSFB during immunosurveillance 
and neuroinflammation is sparse. Live cell imaging of 
single immune cells crossing the BCSFB in  vivo is hin-
dered by the poor accessibility of the CP within the brain 
ventricular spaces and its constant movement due to 
the CSF pulsations. Thus, reliable in vitro models of the 
BCSFB that preserve the differentiated characteristics of 
the choroid plexus epithelium are mandatory to study 
immune cell migration across the BCSFB. Primary cul-
tures of bovine, porcine, sheep, rabbit and rat choroid 
plexus epithelial cells have been established and proven 
as reliable in  vitro models of the BCSFB of the respec-
tive species [14–20]. In addition, a number of cell lines, 
notably the rat cell line Z310 [21–24] and human cell 
lines originating from either CP papillomas [25, 26] or 
carcinomas [27], have been used to model the BCSFB 
in vitro. A number of laboratories have previously estab-
lished in  vitro cultures of primary mouse CP epithelial 
cells [28–31]. However, there is a lack of a comprehen-
sive characterization of these models regarding purity 
and growth as contact-inhibited monolayers, expres-
sion of CP epithelial cell markers, maturation of TJs and 
functional barrier characteristics [30]. Furthermore, an 
optimization of these in vitro models, which would allow 
for the study of immune functions of the mouse BCSFB 
including immune cell migration into the CNS, is still 
missing [8]. Given the availability of gene-targeted mice, 
an in vitro model of the mouse BCSFB would be advan-
tageous to define the role of individual molecules for 
BCSFB immune functions.
The aim of the present study therefore, was to estab-
lish in  vitro models of the mouse BCSFB specifically 
suited to study immune cell migration across the BCSFB 
in a two-chamber setup. To this end we first established 
the isolation and primary culture of mouse CP epithe-
lial cells from different mouse strains. This included the 
Immortomouse®, which expresses the temperature sen-
sitive Simian Virus 40 (tsSV40) large T Antigen under 
the MHC class I promoter and has proven a successful 
source for establishing conditionally immortalized epi-
thelial cell lines from the intestine and other tissues [32, 
33]. In addition, we analyzed the ECPC4 cell line, which 
was produced from CP carcinomas of transgenic mice 
expressing the SV40 large T antigen [34].
The three in vitro BCSFB models were analyzed for the 
development of epithelial contact-inhibited monolay-
ers, expression of cytokeratin and transthyretin as mark-
ers for epithelial cell maturation, maturation of BCSFB 
specific junctional complexes, and the establishment of 
a tight barrier with low permeability to small molecu-
lar tracers with a high transepithelial electrical resist-
ance (TEER). Our novel Immortomouse® derived lines 
and the ECPC4 cells did not fulfill these criteria as they 
lacked expression of cytokeratin and failed to grow into 
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confluent monolayers with barrier characteristics. In 
contrast, highly-purified primary mouse choroid plexus 
epithelial cell (pmCPEC) cultures showed proper expres-
sion and distribution of CP epithelial markers including 
the junctional proteins and readily established a tight 
barrier. Inverted cultures, with pmCPECs grown on the 
lower side of a porous filter membrane, were found to be 
suitable in vitro models of the BCSFB to study the migra-
tion of encephalitogenic T cells across the BCSFB from 
the basolateral (blood facing) to the apical (CSF facing) 
side, which correctly models the in vivo situation.
Methods
Harvesting of choroid plexus tissues
Mice were sacrificed by CO2 inhalation according to the 
approved animal protocol (approval number BE72/15 
of the Cantonal Veterinary Office of the Canton Bern). 
Organ harvest was thus conducted strictly in compliance 
with the legal and ethical requirements demanded by the 
national guidelines and the legislations for animal experi-
mentations. This implements Directive 2010/63/EU on 
the protection of animals used for scientific purposes and 
thus incorporates the principle of the Three Rs.
Primary mouse choroid plexus epithelial cell (pmCPECs) 
isolation and culture
Mouse choroid plexus epithelial cells (CPECs) were 
isolated by a modification of a protocol previously 
established for the isolation of rat CPECs [20]. In brief, 
sex-matched 6–10  week old C57BL/6 mice or Immor-
tomice® (see below) were euthanized with CO2, decapi-
tated and the brain excised. For one preparation, CP was 
removed from 15 to 20 mice from the lateral and the 4th 
ventricles using a stereomicroscope. The CPs were col-
lected, rinsed in Dulbecco’s phosphate buffered saline 
(DPBS, Gibco, Paisley, UK) and digested with 0.1  mg/
ml pronase (Roche, Mannheim, Germany) in DPBS for 
30  min at 37  °C in a shaking water-bath. The digestion 
was ended by addition of 5  ml DPBS without pronase. 
The CP clumps were re-suspended and recovered by sed-
imentation controlled visually by eye. The supernatant, 
which contained mostly single non-epithelial cells and 
debris, was discarded. The sedimented CP clumps were 
further mechanically and enzymatically disaggregated by 
pipetting the clumps up and down for 10 to 20 s (depend-
ing on the size of the clumps) in 1 ml of 0.025 % Trypsin–
EDTA (1×) (Gibco, Paisley, UK) containing 12.5  μg/ml 
DNAse I (Roche, Mannheim, Germany). This procedure 
was followed by a sedimentation step at RT for 1–2 min 
and ended based on visual control of the sedimentation. 
The supernatant, which is enriched for single CP epithe-
lial cells and thus more turbid, was transferred to a new 
tube containing 5 ml of CPEC medium (DMEM/F12 1:1 
(Gibco, Paisley, UK), FBS 10 % (Gibco, Paisley, UK), 2 mM 
glutamine (Gibco, Paisley, UK), 50  μg/ml gentamycine 
(Gibco, Paisley, UK). The procedure of mechanical/enzy-
matic disaggregation and sedimentation was repeated 5× 
as this was found to yield the highest number of CP epi-
thelial cells. The single cell suspensions were pooled and 
pelleted by centrifugation at 800  g for 5  min at RT and 
the pellet was re-suspended in complete CPEC medium, 
which is CPEC medium supplemented with 5  μg/ml 
human insulin (Sigma Aldrich, St. Louis, MO, USA), 
10 ng/ml hEGF (Peprotech, Rocky Hill, NJ, USA), 2 μg/
ml hydrocortisone (Sigma, Buchs, Switzerland), 5 ng/ml 
bFGF (Sigma, Buchs, Switzerland) and 20  μM cytosine 
arabinoside (Ara-C) (Sigma, St. Louis, MO, USA). To 
allow for further enrichment of CP epithelial cells by dif-
ferential attachment to plastic, cells were resuspended in 
4  ml of complete CPEC growth medium and plated on 
2 non-coated petri dishes (PD35), (Becton–Dickinson 
Biosciences (BD Biosciences), Franklin Lakes, NJ, USA). 
After 2–3 h of incubation at 37 °C and 7 % CO2, adher-
ent fibroblasts and macrophages, characterized by their 
extension of cellular processes, were visible under the 
microscope as described [20]. The supernatant was col-
lected and pelleted for 5 min at 800 g. The single cell pel-
let was re-suspended in 0.5  ml complete CPEC growth 
medium and the cells were counted using a hemocytom-
eter. 3 ×  105 cells/cm2 were plated either on permanox 
8-well chamberslides (Thermo Fischer Scientific, Roch-
ester, NY, USA) coated with 20  μg/ml laminin (Roche, 
Mannheim, Germany) for phase contrast microscopy, 
on laminin coated 0.33 cm2 Transwell filters with 0.4 μm 
pore size (Corning, Kennebunk, ME, USA) for immuno-
fluorescence stainings, or on laminin coated 5  μm pore 
size Transwell filters (Corning, Kennebunk, ME, USA) for 
transmigration assays. The cells were allowed to attach to 
the chamber slides or filter membranes at 37 °C and 7 % 
CO2 for 48 h. On day 2 the cells were washed with DPBS 
and the medium was exchanged. The cells were grown 
to confluence for 1 week at 37  °C and 7 % CO2 in com-
plete growth medium, which was changed every other 
day. Continuous presence of the DNA synthesis inhibi-
tor Ara-C specifically suppressed the growth of con-
taminating cells such as stromal fibroblasts. In contrast 
to CPECs, these cells express nucleoside transporters 
unable to distinguish ribose and arabinose residues and 
thus incorporate Ara-C into their genomic DNA, leading 
to the specific suppression of their growth [30, 35].
Establishment of inducible CP epithelial cell lines from the 
Immortomouse®
Immortomice® were obtained from Charles River Labora-
tories (Wilmington, MA, USA). Immortomice® are trans-
genic mice with a thermolabile Simian Virus 40 large T 
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Antigen (SV40 TAg) and limited expression of functional 
SV40 Tag in  vivo, e.g. at 37  °C [36]. At the same time, 
expression of the thermolabile SV40 TAg under the con-
trol of the mouse major histocompatibility complex class 
I allows for further induction of expression by interferonγ 
(IFNγ). CPECs were isolated as described above and 
grown under non-permissive conditions (37 °C and in the 
absence of IFNγ). Upon reaching confluence, CPECs were 
passaged and shifted to permissive conditions (33 °C and 
10 U/ml IFNγ (PeproTech, Rocky Hill, NJ, USA), allowing 
for increased expression of functional SV40 TAg. Conflu-
ent cell layers were split for up to 6 passages under per-
missive conditions accompanied by shifting aliquots of 
the cultures to non-permissive conditions at 37 or 39  °C 
and IFNγ withdrawal. The latter were tested for epithelial 
re-differentiation by evaluating their epithelial morphol-
ogy and by immunostaining for epithelial-specific mol-
ecules. In order to establish conditionally immortalized 
cells, this standard procedure was modified several times 
at every step, as summarized in Table 1.
Culture of the ECPC4 cell line
The mouse carcinoma cell line ECPC4 [34] was pur-
chased from the RIKEN BioResource Center (3-1-1 
Koyadai, Tsukuba, Ibaraki 305-0074, Japan). ECPC4 cells 
were received at passage 37 and used for experiments 
until passage 41. ECPC4 cells were cultured at 37 °C and 
7  % CO2 in 5  ml growth medium (RPMI 1640 (Gibco, 
Paisley, UK)/10 % FBS (Gibco, Paisley, UK) in T25 flasks 
and split in a 1:4 ratio twice per week as described by the 
distributor.
Establishment of ‘inverted’ CPEC cultures
ECPC4 and pmCPECs were cultured on the lower 
(‘inverted’) side of filter inserts using a modification of a 
protocol previously established for porcine and human 
Table 1 Culture options tested for the establishment of conditional immortoCPEC lines
Source (Immortomice®)
Age Sex Genotype Number of mice 
per preparation
2–12 weeks, 20 weeks Female or male tsSV40Tag heterozygous/homozygous 2 or 8–16
Primary culture (33 or 37 °C)
Handling options Culture media supplements
Seeding density Laminin coated  
surface
Duration until  
passaging and/or 
temperature switch
Splitting ratio 
to passage 1
Fetal bovine serum (FBS) Cytosine arabino-
side (AraC)
0.5 × 105–4.5 × 105 cells/cm2
1 × 105 cells/filter
limiting dilution cloning 
(1 cell/0.33 cm2)
Petridishes 35 or 100 mm2
8 well chamberslide
48 well plate
96 well plate
0–6 days
29/36 days (limited 
dilution)
1:2
1:3
1:5
Colony picking
2 % in the absence of 
fibroblast growth factor 
(FGF)
10 % (±FGF)
Days 0–4
De-differentiation under permissive conditions (33 °C + IFNγ)
Handling options Culture media supplements
Temperature switch Splitting ratios Conditioned medium IFNγ Fiborblast 
growth factor 
(FGF)
Fetal bovine 
serum
AraC
With/without splitting of cells 1:2
1:3
1:4
1:5
1:8
limiting dilution 
cloning
±addition of supernatant from HIBCPPs 
(human choroid plexus papilloma cell line)
0 U/ml
5 U/ml
10 U/ml
30 U/ml
50 U/ml
± FGF 2 %
5 %
10 %
±AraC
days 
0–4
Re-differentiation under non-permissive conditions (37 or 39 °C)
Handling options Culture media supplements
Culture duration AraC
7, 10, 14 days day 0–4
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in vitro models of the BCSFB [37]. In brief, CPECs were 
seeded in a volume of 100 μl on the lower side of laminin 
coated Transwell filters placed in inverted position in 
12-well plates. The cells were seeded at the same density 
as on standard filter sides. After incubation for 24 and 
48  h for ECPC4 and pmCPECs, respectively, the cells 
were washed twice with DPBS and the filters were flipped 
and placed into their original 24-well plate filled with 0.5 
and 1  ml of growth medium per well in the upper and 
lower compartment, respectively.
Antibodies and buffers for immunofluorescence staining
The following primary antibodies were used for immu-
nofluorescence staining: monoclonal mouse anti-pan 
Cytokeratin (mixture) antibody (1:100), (Sigma, C2562, 
St. Louis, MO, USA), monoclonal mouse anti-human 
E-cadherin (BD Biosciences, Franklin Lakes, NJ, USA, 
catalog number 610181, 10  μg/ml), monoclonal mouse 
anti-β-catenin (BD Biosciences, Franklin Lakes, NJ, USA, 
catalog number 610154, 10  μg/ml), polyclonal rabbit 
anti-human transthyretin (TTR) (Dako, Glostrup, Den-
mark, catalog number A0002, 4.5 μg/ml), polyclonal rab-
bit anti-claudin-1 (Cldn-1) (Invitrogen, Camarillo, CA, 
USA, catalog number 519000, 5 μg/ml), polyclonal rabbit 
anti-claudin-2, or -3 or -11 (Invitrogen, Camarillo, CA, 
USA, catalog numbers 516100, 341700, 364500, respec-
tively, 10 μg/ml), polyclonal rabbit anti-zonula occludens 
1 (ZO1) (Invitrogen, Camarillo, CA, USA, catalog num-
ber 617300, 5 μg/ml), and polyclonal goat anti-huVimen-
tin (1:20, Chemicon International Inc. Temecula, CA, 
USA, catalog number AB1620). Rat anti-mouse ICAM-1 
(25ZC7) and rat anti-mouse VCAM-1 (9DB3) were used 
as hybridoma culture supernatants.
The following 2nd stage antibodies were used: Cy3 
donkey anti-mouse IgG (H  +  L) (Jackson ImmunoRe-
search, West Grove, PA, USA, catalog number 715-165-
151, 2.5  μg/ml), Alexa488 goat anti-rabbit IgG (H +  L) 
(Invitrogen, Eugene, OR, USA, catalog number A11034 
10 μg/ml), and Cy3 donkey anti-goat IgG (H + L) (Jack-
son ImmunoResearch, West Grove, PA, USA, catalog 
number 705-165-147, 7 μg/ml), and Cy3 donkey anti-rat 
IgG (H + L) (Jackson ImmunoResearch, West Grove, PA, 
USA, catalog number 712-165-150, 2.5  μg/ml). The fol-
lowing buffers were made in house: 10 ×  TBS (50  mM 
Trizma Base (Sigma, St. Louis, MO, USA), 150 mM NaCl 
(Sigma, Buchs, Switzerland), 1  mM CaCl2·2H2O (Sigma 
St. Louis, MO, USA), adjusted to pH 7.4).
Immunofluorescence staining
Confluent cell layers grown on Transwell filters (Corn-
ing, Kennebunk, ME, USA) were gently washed with 
warm DPBS and subsequently fixed with either 1 % para-
formaldehyde (PFA, MERCK, Darmstadt, Germany) in 
DPBS at RT for 10  min or with −20  °C methanol (for 
claudin and occludin staining) for 1 min. After fixation, 
the cells were washed 5× with DPBS. Blocking solution 
(5 % skimmed milk (Rapilait, Migros, Switzerland), 0.3 % 
Triton-X-100 (Schweizerhall, Basel, Switzerland Batch 
Nr. A11021), 0.04  % NaN3 (Fluka Chemie, Buchs, Swit-
zerland) in TBS pH 7.4) was incubated for 20 min at RT. 
Subsequently 35 μl of blocking buffer containing the 1st 
antibody was added for 1 h at RT. The primary antibody 
was removed from the cell layer by 5 washing steps with 
DPBS and 35  μl of blocking buffer containing the 2nd 
antibody was added to the filter inserts and incubated 
light protected for 45 min at RT. The cells were washed 
5× with DPBS and incubated under light protection with 
1 μg/ml 4′,6-diamidin-2-phenylindol (DAPI, AppliChem, 
Darmstadt, Germany) in DPBS for 2  min at RT. After 
washing 3× with DPBS, the cell carrying filters were cut 
out from the inserts, plated on glass-slides and mounted 
with embedding medium Mowiol (Sigma-Aldrich, 
Steinheim, Germany) prior to fluorescence microscopy. 
Immunostaining for cell surface ICAM-1 and VCAM-1 
was performed on live cells. To this end live cells were 
incubated with the hybridoma culture supernatants for 
20  min at RT. After washing with DPBS, the cells were 
fixed with 1  % formaldehyde in PBS for 5  min at RT, 
washed with DPBS for 10 min at RT and then incubated 
with the secondary antibody for 20 min at RT in the dark. 
After washing 3× with DPBS, the cell-carrying filters 
were cut out from the inserts, plated on glass-slides and 
mounted with embedding medium Mowiol prior to fluo-
rescence microscopy.
Transepithelial electrical resistance
The transepithelial electrical resistance (TEER) across 
the CPEC monolayers was analyzed in triplicate by 
impedance spectroscopy employing the cellZscope 
R (Nanoanalytics, Muenster, Germany) according to 
the manufacturer’s instructions. To this end cells were 
seeded on laminin coated 0.4 μm poresized filter inserts 
(Corning, Kennebunk, ME, USA or Greiner bio-one, 
Frickenhausen, Germany) in standard or inverted culture 
as described above. Upon complete pmCPECs attach-
ment after 48 h, the filters were turned upside down and 
the medium was added to both compartments of the fil-
ter system allowing for further proliferation of the cells. 
The pmCPECs were transferred into the cellZscope and 
the TEER was measured over the last 72 h in culture to 
monitor the achievement of the resistance plateau. The 
ECPC4 cells were split in a 1:4 ratio as recommended by 
the distributor without counting the cells, and plated on 
standard and inverted sides of laminin coated Transwell 
filters. Upon attachment of ECPC4 cells to the porous 
membranes after 24  h, the filters were transferred into 
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the cellZscope where they grew to confluence for fur-
ther 3  days. One point TEER measurement of titrated 
and serum-depleted ECPC4 cells was performed every 
24  h using the EndOhm-6 device (World Precision 
Instruments, Inc. Sarasota, FL, USA). Therefore, the fil-
ter inserts were transferred one by one into the cham-
ber containing pre-warmed culture medium. In order to 
obtain accurate results, hydrostatic pressure on the mem-
branes and air bubble formation were carefully avoided. 
The electrode was centered within the chamber and the 
TEER was measured using the Millicell Electrical Resist-
ance System-2 epithelial volt-ohm meter (Millipore Cor-
poration, Billerica, MA, USA). The displayed values were 
divided by the surface area of the filters, in order to yield 
the net resistances of the cell monolayers. Blank laminin 
coated inserts were used as empty filter references.
Transepithelial permeability
Prior to barrier investigations, the cells were seeded 
on laminin coated 0.33  cm2 Transwell (Corning, Ken-
nebunk, ME, USA) filters, pore diameter 0.4  μm, and 
the pmCPECs and ECPC4 cells were incubated for 48 
and 24  h, respectively. Next, both compartments of the 
Transwell filter system were filled with fresh medium and 
the cells were cultured for further 5 days (pmCPECs) or 
2–3  days (ECPC4). The paracellular permeability across 
the epithelial monolayers was measured in triplicate 
exactly as previously described [38, 39]. In brief, prior 
to experiments, 3 kDa dextran coupled with Alexa Fluor 
680 (Molecular Probes, Eugene, OR, USA) was diluted, 
light protected, in assay medium (DMEM (Gibco, Paisley, 
UK), 5 % FCS (Gibco, Paisley, UK), 25 mM Hepes (Gibco, 
Paisley, UK), 2  % l-glutamine Gibco, Paisley, UK) to a 
final concentration of 10 μg/ml. 600 μl of the dextran free 
assay medium was added to the bottom of each well of 
an empty 24-Transwell plate (Corning, Kennebunk, ME, 
USA). Permeability assays were always performed on the 
same CPEC cultures previously analyzed for TEER. Fil-
ters were washed once with assay medium, and 100 μl of 
the dextran solution was added to the upper side of the 
filter inserts, which were subsequently placed into wells 
containing 600 μl of assay medium. The plate was incu-
bated at 37  °C and the inserts were replaced into wells 
containing fresh assay medium, avoiding long exposure 
to light and room temperature every 10 min. 200 μl sam-
ples from all lower compartments were transferred to a 
96-well plate. The dextran permeability was measured 
by scanning the 200  μl samples in the 96-well plate by 
infrared imaging (Odyssey Quantitative Fluorescence 
Imaging System, LI-COR, Bad Homburg, Germany). The 
epithelial permeability coefficient (Pe) was calculated 
using the clearance principle to obtain a concentration-
independent transport parameter as previously described 
in detail [39]. A standard dilution curve (1 μg/ml–0.1 ng/
ml) and empty filters were used to obtain the reference 
permeability of the empty filter inserts. The permeabil-
ity coefficient for the in vitro BCSFB models was calcu-
lated as follows: the slope of the average tracer volume 
cleared was plotted versus time in order to obtain the lin-
ear regression designated as PSt. The slope of the tracer 
clearance curve of the coated empty filters was indicated 
as PSf. The permeability surface area product of the epi-
thelial cell monolayer (PSe) was calculated from PSt and 
PSf: 1/PSe = 1/PSt − 1/PSf. The PSe was divided by the 
filter surface area, in order to generate the epithelial Pe in 
cm/min.
The cell layer Pe for Lucifer Yellow (LY) (Sigma, St. 
Louis, MO, USA)—MW 457.3  g/mol diluted in assay 
medium—was determined as previously published in [40] 
according to the permeability assay for 3 kDa described 
above, with the assay medium being HBSS (1×) without 
phenol red (Gibco, Paisley, UK), supplemented with 5 % 
FCS and 25  mM Hepes, the LY solution of 50  μM and 
the LY standard dilution curve measured for 20–0.05 μM 
LY. The fluorescence detection was performed using the 
Tecan Infinite M1000 device and the Tecan i-control 
software (Tecan Trading AG, Männerdorf, Switzerland). 
Calculation of the Pe values by this methodology pro-
vides numbers to the 8th decimal. Entering these math-
ematically-correct numbers into the GraphPad Prism 
6 Software for statistical analysis provides values to the 
3rd decimal. These mathematically correct Pe values are 
shown in the “Results”.
T cell migration across the BCSFB in vitro
In order to assure an unhindered passing of immune cells 
through the filter pores during the transmigration assay, 
the CPEC cells were seeded on laminin-coated inverted 
filters with 5  μm pore size. Inverted pmCPEC cultures 
were stimulated or not with TNFα (PromoCell GmbH, 
Heidelberg, Germany) (10  ng/ml) or IFNγ (100  U/ml) 
16  h prior to the experiment. Encephalitogenic CD4+ 
Th1 effector/memory proteolipid protein (PLP) peptide 
aa139–153 specific T cells (line SJL/PLP7) were cultured 
as previously described [41]. On the day of the assay the 
CD4+ T cells were collected in migrations-assay medium 
(MAM: DMEM (Gibco, Paisley, UK), 2  % l-Glutamine, 
25 mM Hepes (Gibco, Paisley, UK), 5 % Calf Serum (CS) 
(Sigma, St. Louis, MO, USA)). pmCPEC inserts were 
washed with MAM twice before transferred into a new 
24-well Costar plate well containing 600  μl of MAM. 
100 μl of MAM containing 1 × 105 T cells was added per 
insert and T cells were allowed to transmigrate for 8 h at 
37 °C. Additionally, a triplicate of input cell suspensions 
containing 1  ×  105/600  μl of MAM were pipetted into 
24-well plate wells. The number of transmigrated T cells, 
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the number of the cells in input samples and their viabili-
ties were assessed by the CASY Cell counter and analyzer 
(Schärfe System, Reutlingen, Germany) according to the 
manufacturer’s instructions. The percentage of migrated 
T cells was calculated referring to the inputs as 100 %.
Statistical analysis
One-way ANOVA was performed followed by the 
Tukey multiple comparison test to compare three or 
more groups. For comparison of two groups, a Mann–
Whitney test was performed. Results were expressed as 
mean ± SD and a P value <0.05 was considered signifi-
cant. Statistical analysis was performed using the Graph-
Pad Prism 6 software (GraphPad, San Diego, CA, USA).
Results
Isolation and culture of highly purified primary mouse 
choroid plexus epithelial cells (pmCPECs)
In order to provide a suitable in vitro model of the mouse 
BCSFB to investigate the cellular and molecular mecha-
nisms mediating immune cell migration across the 
BCSFB, we established a procedure for the isolation and 
culture of highly purified primary mouse choroid plexus 
epithelial cells (pmCPECs) by adapting a previously-pub-
lished protocol for the isolation and culture of rat cho-
roid plexus epithelial cells [20]. CPECs were isolated by 
enzymatic digestion followed by a combined mechanical 
and enzymatic disaggregation of the choroid plexus from 
the lateral and 4th ventricles of sex and age matched 
mice. The preparations yielded 3.3–4.5 × 104 CPECs per 
mouse. The cells were plated on laminin-coated supports 
in a density of 3 × 105/cm2. The pmCPECs formed islets 
of cuboidal shaped cells that within 5–7  days grew into 
confluent monolayers showing contact inhibition (Fig. 1). 
We did notice the occasional appearance of incompletely 
processed CP tissue particles (asterisk, Fig.  1a) and the 
formation of small dome-like epithelial structures after 
one week of culture (asterisk, Fig.  1b). The high purity 
of the CPEC culture was confirmed by positive immu-
nofluorescence (IF) staining for cytokeratin in >95  % of 
cells within the monolayer. Junctional maturation was 
confirmed by the junctional localization of tight junction 
proteins, e.g. claudin-1 (e.g. Fig.  4b). Thus our protocol 
enabled the isolation and growth of highly pure mouse 
choroid plexus epithelial cells.
Conditionally immortalized Immortomouse® derived CPEC 
lines fail to re-differentiate into mature CPECs
Having established primary cultures of pmCPECs, we 
next aimed to establish conditionally immortalized CPEC 
lines which would produce proliferating cultures and 
thus reduce the number of mice needed for the in vitro 
model. The Immortomouse® that carries the thermo-
labile SV40 large T antigen under the control of an IFNγ 
inducible MHC class I promoter was used [36]. Previous 
studies have successfully used this mouse model to estab-
lish conditionally immortalized epithelial cell lines from 
other tissues [32].
When grown under non-permissive conditions (37 °C, 
no IFNγ) primary cultures of Immortomouse® CPECs 
were indistinguishable from CPECs of C57BL/6 mice 
(Fig.  2a). When placed under permissive conditions 
(33 °C, 10 U IFNγ) the CPECs started to proliferate and 
rapidly lost their typical cuboidal morphology start-
ing in areas of lower cell density at the edges of the cul-
ture dishes while CPECs in the center of epithelial islets 
kept their cuboidal morphology (Fig.  2b). Immortalized 
CPECs also lost BCSFB specific expression of receptors 
and barrier functions as addition of the DNA synthesis 
inhibitor cytosine arabinoside (Ara-C) induced the cell 
Fig. 1 Morphology of confluent primary mouse choroid plexus epithelial cells (pmCPECs). Representative phase contrast pictures of cells plated 
directly after choroid plexus dissection and cell disaggregation and cultured in complete growth medium for 8 days. The pmCPECs exhibit a 
predominant polygonal morphology with rare unprocessed tissue remnants (asterisk) visible in a and occasional dome like cell aggregates (asterisk) 
visible in b. The contrast of picture a was enhanced using Adobe Photoshop software. Scale bar in a = 50 μm and in b = 100 μm
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death of the immortalized CPECs. Furthermore, the cells 
showed expression of the mesenchymal intermediate 
filament vimentin (Fig.  2c). Loss of epithelial cell mor-
phology and contact inhibition was accompanied by the 
continuous loss of expression of cytokeratin as well as 
loss of expression and junctional localization of E-cad-
herin and the choroid plexus specific claudins (claudin-1, 
-2, -3, -11) shown here over several passages (Fig. 2d).
Fig. 2 Phenotype and irreversible de-differentiation of Immortomouse® CPECs. a Primary Immortomouse® choroid plexus epithelial cells (p0) 
grown at 37 °C for 7 days showed the same staining patterns for cytokeratin (CK) and claudin-1 (Cldn-1) as pmCPECs isolated from wild-type mice. 
b When Immortomouse® CPECs were grown under permissive conditions (33 °C, 10U IFNγ) the heterogenous de-differentiation process started in 
areas with low cell density, whereas CPECs kept their cuboidal shape longer in areas with high cell density. The contrast of the pictures in a and b 
was enhanced using Adobe Photoshop software. c Vimentin staining, rather than CK staining was observed at 33 °C. Cell death took place at 33 °C 
upon Ara-C addition to culture. d The irreversible loss of CPEC specific markers Cldn-1 and CK and an increasing proliferation rate of de-differenti-
ated Immortomouse® CPECs was observed with increased passage. The first row is passage 2 (p2), the second row is p3, the third row is p4. e The 
cells failed to form confluent monolayers or display the correct expression pattern of epithelial markers upon shift to non-permissive temperature 
and IFNγ withdrawal. Immortomouse® CPECs in e were stained after 7 days of non-permissive growth; the passage numbers (p) were E-cad/DAPI: 
p8, ZO1/β-Cat/DAPI: p5, Cldn11/N-Cad/DAPI: p6, Cldn-1/CK/DAPI: p4. Scale bar in all immunofluorescent and phase contrast pictures = 100 μm. 
p0 primary culture, E-Cad E-cadherin, N-Cad N-cadherin, Cldn-1 Claudin 1, Cldn-11 Claudin 11, CK cytokeratin, β-Cat β-Catenin, ZO1 zona occludens 
protein 1
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Re-differentiation of the immortalized CPECs was 
attempted after passages 1–6 at 37 or 39  °C and with-
drawal of IFNγ with re-differentiation at 39  °C found 
to be more effective. Evidence for re-differentiation of 
the immortalized CPECs into epithelial cells was docu-
mented by the re-expression of cytokeratin in a few 
epithelial cells and the partial reconstitution of AJs 
(detection of junctional localization of E/N-cadherin and 
β-catenin) and TJs (detection of junctional localization of 
ZO-1, claudin-1, claudin-11) (Fig. 2c, e and not shown). 
Unfortunately this process was limited to small, incoher-
ent islands of epithelial cells and remained incomplete 
due to the continued expression of vimentin in the cul-
tured cells and cytoplasmic detection of junctional mol-
ecules irrespective of passage number (Fig. 2e).
Interestingly, the addition of Ara-C to highly prolifer-
ating Immortomouse® CPECs at non-permissive con-
ditions did not induce massive cell death during the 
re-differentiation time of 7–14 days. However, a selection 
for re-differentiated cuboidal epithelial cells could not be 
achieved (data not shown).
In a next step we compared a possible advantage of 
establishing CPEC lines from Immortomice® homozy-
gous (T/T) or heterozygous (T/+) for the tsSV40Tag. 
Indeed we found that under permissive conditions 
Immortomouse® CPECs from mice homozygous for the 
tsSV40TAg (T/T) proliferated faster than those from het-
erozygous mice (T/+) (data not shown) but irrespective 
of their genotype they equally failed to re-differentiate 
into CP epithelial cells in different passages.
We further tested different concentrations of FBS and 
found that increasing concentrations of FBS in the CPEC 
cultures increased the proliferation rate of the immor-
talized cells, but reducing FBS concentrations under 
non-permissive conditions did not improve re-differen-
tiation of the CPEC cell lines. Similarly, propagation of 
the CPEC lines also correlated with the concentration 
of IFN-γ. When propagating CPEC lines from Immor-
tomice® at 33  °C in the absence or presence of increas-
ing concentrations of IFN-γ we found that in the absence 
of IFN-γ, CPECs also lost their cuboidal morphology but 
died after passaging due to their poor proliferation abil-
ity. In contrast, increasing concentrations of IFN-γ up 
to 50 U/ml allowed us to propagate the CPECs over sev-
eral passages. This supported the notion that the level of 
SV40Tag expression is critical for cell propagation. How-
ever, we did not observe improved re-differentiation of 
the CPEC lines when propagated in the absence or in the 
presence of higher concentrations of IFN-γ.
Thus, although we successfully established primary 
cultures of Immortomouse® CPECs and could read-
ily propagate these cells, a total of 15 different trials 
applying different handling options and culture media 
(summarized in Table 1) failed to achieve successful re-
differentiation of Immortomouse® CPECs. We therefore 
concluded that in contrast to other tissues the Immor-
tomouse® is not a good source for establishing in  vitro 
models of the mouse BCSFB.
Phenotypic characterization of the mouse choroid plexus 
carcinoma cell line ECPC4
Next we investigated the suitability of the commer-
cially available mouse choroid plexus carcinoma cell 
line ECPC4 as an in vitro model to study immune func-
tion of the mouse BCSFB. ECPC4 cells were reported 
to be a useful model to study the BCSFB in vitro as they 
retain the characteristics of CPECs as shown by expres-
sion of BCSFB-specific proteins such as transthyretin 
and alpha2-macroglobulin [34]. When cultured accord-
ing to the protocol of the manufacturer, ECPC4 cells 
grew with a high proliferation rate starting with a fibro-
blast like morphology (Fig. 3a) into confluent cell layers 
showing incomplete contact inhibition and thus partial 
overgrowth (Fig. 3b). In order to determine if exogenous 
addition of extracellular matrix proteins would improve 
monolayer formation by ECPC4, culture dishes were 
coated with laminin, rat-tail collagen, gelatin or poly-
l-lysine on different glass and plastic surfaces. Irrespec-
tive of the condition chosen, we failed to observe any 
change in the proliferation rate or quality of monolayer 
formation of ECPC4 cells (data not shown).
To establish an in  vitro model accessible from both 
sides and therefore suitable to study the migration of 
immune cells across the BSCFB, we cultured ECPC4 
cells on porous membranes and tested their growth and 
viability. For our experiments we plated the ECPC4 cells 
directly on laminin coated filter inserts with a growth 
area of 0.33 cm2 and let them grow to confluence.
To determine their CPEC specific characteristics we 
next performed immunofluorescence (IF) staining for 
CPEC specific molecules. We first confirmed expres-
sion of transthyretin (TTR), which is known to be highly 
expressed in the CP in vivo, in the cultured ECPC4 cells 
in a similar fashion as in Immortomouse® CPECs and 
pmCPECs (Fig.  3c). However, we could not detect the 
epithelial cell specific intermediate filament cytokera-
tin. Rather ECPC4 cells stained positive for the mesen-
chymal intermediate filament protein vimentin. Staining 
for the AJ molecules E-cadherin and β-catenin and the 
TJ proteins occludin, claudin-1, -2, -3 and -11 and ZO-1 
showed interrupted junctional localization or no detect-
able expression, underscoring the immaturity of the junc-
tional complexes between ECPC4 cells (Fig. 4a and data 
not shown). Thus although ECPC4 cells express CP char-
acteristic proteins they fail to establish contact-inhibited 
monolayers with mature junctional complexes.
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Phenotypic characterization of primary mouse choroid 
plexus epithelial cells (pmCPECs)
We next asked if pmCPECs grown on porous filter inserts 
will form monolayers with intact junctional complexes. 
We plated the freshly isolated choroid plexus single cell 
suspensions directly on laminin-coated filter inserts with 
a growth area of 0.33 cm2 to avoid passaging and let the 
cells proliferate until they attained confluence. Immuno-
fluorescence staining showed expression of TTR (data 
not shown) and the epithelial cell specific intermediate 
filament protein cytokeratin in >95 % of cells in the mon-
olayer. In addition we observed continuous junctional 
staining for the AJ proteins E-cadherin and β-catenin 
and the TJ proteins claudin-1, -2, -3, -11, occudin and 
ZO-1 between the pmCPECs (Fig. 4b). Hence the immu-
nostaining confirmed the high purity and the estab-
lishment of mature junctional complexes in pmCPEC 
cultures.
Comparison of barrier characteristics of ECPC4 
and pmCPECs
To determine if the immunofluorescence staining of 
ECPC4 and pmCPECs correlated with their barrier 
characteristics we next established for both CPECs the 
‘inverted’ culture as previously described for porcine 
CPECs [37]. To allow investigation of immune cell migra-
tion from the blood to the CSF side, CPECs were seeded 
on the lower surface of inverted filter inserts, which 
once the CPECs had attached, were turned around for 
performing the respective assays. Neither ECPC4 nor 
pmCPECs showed a difference in growth rate or differ-
entiation when grown on the lower filter site compared 
to the upper filter site as confirmed by light microscopy 
and immunofluorescence staining for epithelial and junc-
tional molecules exactly as described above (data not 
shown).
To determine the efficacy of the pmCPECs and the 
ECPC4 cell line to form a tight barrier with sealing junc-
tional complexes between adjacent cells, we measured 
the TEER of the cultured cells over the last 72 h in cul-
ture to monitor the achievement of the resistance plateau 
by impedance spectroscopy. In parallel, the TEER was 
measured over empty laminin-coated filters as negative 
controls. After 7 days in culture, pmCPEC layers reached 
a TEER plateau between 100 and 200  Ω  cm2 (Fig.  5a), 
which is similar to TEER values previously measured 
across rat CPE monolayers, being 178  Ω  cm2 [20] and 
are slightly higher than those previously observed across 
mouse CPECs [8]. Interestingly, the inverted pmCPEC 
cultures displayed a significantly higher TEER than the 
standard cultures, shown by the calculated area under 
the curve (AUC) (Units: Ω cm2 h) (Fig. 5a). However, the 
morphology of the pmCPECs growing on either side of 
the filter was indistinguishable (Fig. 5d).
Fig. 3 Morphology, expression of transthyretin and propagation of ECPC4 cells. Representative phase contrast pictures of ECPC4 cells from passage 
41 on d1 (a) and d4 (b) after sub-cultured in a 1:4 ratio as described by the distributer. The cells did not show typical epithelial morphology (a, b) 
and grew in overlapping layers (b). Scale bars 50 μm. c Immunofluorescence staining for the CPEC-specific marker transthyretin (TTR) is shown in 
pmCPECs, Immortomouse® CPECs from passage 6, grown for 7 days at non-permissive conditions and for the ECPC4 cells. Scale bars a, b and ECPC4 
cells = 50 μm; pmCPECs and Immortomouse® CPECs = 100 μm
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Irrespective if grown in standard or inverted filters, 
the ECPC4 cells failed to establish a barrier with regard 
to TEER measurements. With 10 Ω cm2 the TEER meas-
ured across ECPC4 monolayers remained close to the 
TEER values measured across laminin-coated empty fil-
ters (Fig. 5a).
The barrier characteristics of the CPEC monolayers 
were investigated by measuring the paracellular diffu-
sion of the small water soluble tracers 3  kDa dextran 
and Lucifer Yellow (LY, MW 457  Da) across the epi-
thelial monolayers for 40  min. Monolayers layers of 
pmCPEC established a tight barrier with permeabil-
ity coefficients Pe3kDa  =  0.024  ±  0.021  ×  10−3  cm/min 
and Pe3kDa  =  0.017  ±  0.018  ×  10−3  cm/min for stand-
ard and inverted filter cultures, respectively (Fig.  5b). 
As expected, the permeability for the small tracer LY 
was higher than that observed for the larger 3 kDa dex-
tran with PeLY  =  0.173  ±  0.014  ×  10−3  cm/min and 
Fig. 4 Phenotype of ECPC4 cells and primary mouse choroid plexus epithelial cells (pmCPECs). Immunofluorescence staining for CPEC specific 
proteins is shown in ECPC4 cells (a) and pmCPECs (b). a There is weak staining for the adhesion junction (AJ) protein E-Cadherin (E-Cad) and its 
cytoskeleton linker β-catenin (β-Cat) of ECPC4 cells and their localization is not specifically at the plasma membrane. Staining for tight junctional 
(TJ) claudins-1 and -11 was absent or showed a weak cytosolic pattern, respectively. The scaffolding protein ZO1 staining was disrupted. Addition-
ally, the cell line failed to stain for the early epithelial marker cytokeratin but rather was positive for the mesenchymal intermediate filament protein 
vimentin. ECPC4 cells from passage 41 were stained on d4 in culture. b In contrast, the staining of pmCPECs stained on d7 in culture, revealed a 
proper distribution of all epithelial markers. pmCPECs. All staining was performed at least 3 times. Scale bars 50 μm. E-Cad E-cadherin, Cldn-1 Claudin 
1, Cldn-11 claudin 11, CK cytokeratin, β-Cat β-catenin, ZO-1 zona occludens protein 1
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Fig. 5 Comparison of barrier characteristics of ECPC4 versus pmCPECs. a The time-dependent progression of the transepithelial electrical resist-
ance (TEER) of ECPC4 cells and pmCPECs grown on standard (luminal) or inverted (abluminal) Transwell filter inserts was measured by impedance 
spectroscopy using the cellZscope device. The TEER of ECPE4 hardly differs from the TEER measured across laminin coated empty filters (EF). In con-
trast, pmCPECs reach a TEER of 150–200 Ω cm2 on d7. The figure shows one representative experiment (of 4) of pmCPECs in comparison to ECPC4 
over their last 72 h in culture with 3 filters per condition and 1 empty filter. The colored lines show the mean TEER values of triplicate measurements 
surrounded by colored areas, which represent the SD. The area under the curve (AUC) as a measure for the overall TEER across the cellular barriers 
over time (Unit: Ω cm2 h) was assessed for a comparison of the overall resistance of the cell layers. *p < 0.05. b, c The permeability for Alexa Fluor 
680-3 kDa dextran (Pe3kDa) (b) was measured in 5 independent experiments with at least three filters per condition (ECPC4 standard: n = 3, ECPC4 
inverted: n = 3, pmCPECs standard: n = 5, pmCPECs inverted n = 4) and the permeability for 457 Da Lucifer Yellow (PeLY) was measured once with 
at least 3 filters per condition (ECPC4 standard: n = 3, ECPC inverted: n = 3, pmCPECs standard: n = 5, pmCPECs inverted: n = 4) ****p < 0.0001 (c). 
d Immunofluorescence staining for claudin-1 (Cldn-1), cytokeratin (CK) and nuclei (DAPI) showed no differences between monolayers grown on 
the upper (standard) or lower (inverted) side of the filter. Scale bar 100 μm. Bars in b, c represent the mean permeability coefficients Pe ± SD
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PeLY =  0.173 ±  0.021 ×  10−3  cm/min for standard and 
inverted filter pmCPEC cultures, respectively (Fig. 5c).
To compare pmCPEC barrier characteristics with those 
of ECPC4 monolayers, diffusion of 3 kDa dextran and LY 
was assessed in the same assays for the ECPC4 in paral-
lel and found to be significantly higher than the Pe values 
measured for pmCPECs. Specifically, the permeability 
coefficient for 3  kDa dextran across ECPC4 was Pe3kDa 
=  0.889 ±  0.311 ×  10−3  cm/min and Pe3kDa =  1.272 ±   
0.720 × 10−3 cm/min for standard and inverted filter cul-
tures, respectively (Fig. 5b). For LY, the permeability coef-
ficients were PeLY =  1.883 ±  0.198 ×  10−3 cm/min and 
PeLY =  1.687 ±  0.351 ×  10−3  cm/min for standard and 
inverted filter cultures respectively (Fig. 5c). Thus, in con-
trast to pmCPECs ECPC4 failed to establish a tight bar-
rier model in vitro.
Considering the different growth characteristics of 
ECPC4 versus pmCPECs we asked if optimizing the 
growth conditions of the ECPC4 cells on the filter inserts 
might improve their barrier characteristics. To this 
end we performed a titration of the ECPC4 cells on the 
laminin-coated filters to optimize their seeding concen-
tration. ECPC4 cells were plated in two experiments at 
different concentrations (5 ×  104, 1 ×  105 and 5 ×  105 
cells per filter) and compared to the standard recom-
mended by the distributor (ECPC4 split in a 1:4 ratio, 
concentration not known) and once at a lower concen-
tration (1 × 104 cells per filter). The TEER of the ECPC4 
cell layer was measured manually using the EndOhm 
device once per day on d3 and d4. The TEER of the cell 
layers with the maximum value being 22  Ω  cm2 was 
slightly higher than that of the empty filters with 12 Ω 
cm2 (Fig.  6a). Next, we investigated the permeability of 
these titrated cells for 3 kDa dextran on day 4 in culture. 
Despite different seeding concentrations, the perme-
ability coefficient for the ECPC4 cell layers was however 
similar, ranging from Pe3kDa =  1.220 ×  10−3  cm/min to 
Pe3kDa  =  0.775  ×  10−3  cm/min (Fig.  6b). The ECPC4 
plated at the lower concentration of 104 cells per filter 
showed an even higher PekDa  =  3.340  ×  10−3 cm/min 
(data not shown). Immunofluorescence staining of the 
filters for ZO-1 and F-actin binding rhodamine phalloi-
din following the permeability measurements, confirmed 
closed monolayers without contact inhibition with higher 
and lower cell numbers (data not shown). Thus, changing 
the number of ECPE4 growing on filter inserts did not 
improve the barrier characteristics of these cells.
To change cell-substrate contacts as previously reported 
[42] we next investigated if ECPC4 grown on polyester 
(PET) instead of polycarbonate filter inserts have improved 
barrier properties and failed to find any improvement (data 
not shown). Finally, as serum withdrawal from the culture 
medium has been reported to result in improved barriers 
of porcine CPECs [15] we investigated if ECPC4 barrier 
properties improve after serum withdrawal from d2 to d4 
after seeding. Serum withdrawal did not affect the mon-
olayer integrity, however, it also failed to improve barrier 
characteristics of ECPC4 when compared to those contin-
uously grown in 10 % FBS (data not shown). In summary, 
we conclude that in contrary to the commercially available 
ECPC4 cell line, the pmCPEC cultures form a tight cellular 
barrier when grown on filter inserts and are thus suited as 
in vitro model for the mouse BCSFB.
Comparison of barrier characteristics of pmCPECs on 0.4 
and 5 μm pore sized filters
Having established a tight in  vitro model of the mouse 
BCSFB we next adapted this model to the growth on 
Fig. 6 Barrier properties of titrated ECPC4 cells growing on Transwell filter inserts. a Different numbers of ECPC4 cells (5 × 104, 1 × 105, 5 × 105 and 
standard) were plated on the inverted porous filter membranes in triplicate. Standard = ECPC4 continuously split in a ratio 1:4, according to the 
distributer’s protocol (number of cells not counted). TEER was measured manually once per day on d3 and d4 in culture using the EndOhm device. 
The cells failed to build up a resistance irrespective of their seeding density. b The permeability coefficient (Pe) for Alexa Fluor 680–3 kDa dextran 
was assessed after the resistance measurement on d4. Bars represent the mean ± SD of all filters from two independent experiments, n = 6 for all 
groups
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inverted filters with a larger pore size of 5  μm allowing 
immune cells to reach the pmCPEC monolayer from the 
upper filter compartment.
In order compare barrier integrities of pmCPECs 
grown to confluence on 5  μm pore versus 0.4  μm pore 
inverted filters, the time-dependent progression of the 
TEER was measured by impedance spectroscopy using 
cellZscope from d3 to d7 of culture (Fig.  7a). Monolay-
ers of pmCPEC reached TEER values between 100 and 
150  Ω  cm2 on day 7 of culture. Although the TEER of 
pmCPECs grown on 0.4  μm pore filters seemed appar-
ently higher, this difference was not significant, as shown 
Fig. 7 Comparison of barrier characteristics of inverted cultures of pmCPECs on filters with 0.4 and 5 μm pores. a The time dependent progres-
sion of the transepithelial electrical resistance (TEER) of pmCPECs grown or inverted (abluminal) Transwell filter inserts with 0.4 and 5 μm pores was 
measured by impedance spectroscopy using the cellZscope device from d3 to d7 in culture. The pmCPECs on both kinds of filters reached a TEER 
of 100–150 Ω cm2 on d7. The figure shows one experiment with 3 filters per condition and 3 empty filters per condition. The colored lines show the 
mean TEER values of triplicate measurements surrounded by colored areas, which represent the SD. The area under the curve (AUC; Units: Ω cm2 h) 
was assessed for a comparison of the overall resistance of the cell layers over time with no significant difference detected. b, c The permeability of 
the pmCPEC grown on inverted Transwell filter inserts with 0.4 and 5 μm pores for two different small molecular tracers was determined following 
the TEER measurements in 1 experiment with n = 4 filters per condition. There was no difference for the permeability of Alexa Fluor 680–3 kDa 
dextran (Pe3kDa) (b) or for 457 Da Lucifer Yellow (PeLY) (c) across the pmCPECs cultured on either type of filter. d Immunofluorescence staining for 
claudin-1 (Cldn-1), cytokeratin (CK) and nuclei (DAPI) on pmCPEC monolayers grown on the inverted sides of filter inserts with 0.4 and 5 μm pores. 
The difference in clarity between the pictures is due to different microscopic characteristics of the filters. Scale bar 100 μm. Bars represent the mean 
permeability coefficients Pe ± SD
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by the calculated AUC of the TEER over time. Further-
more, the permeability of the pmCPEC grown on fil-
ter inserts with 0.4 and 5  μm pores for the Alexa Fluor 
680–3  kDa dextran (Pe3kDa) and 457  Da Lucifer Yellow 
(PeLY) (Fig. 7b, c) was comparable. The permeability coef-
ficient for 3  kDa dextran was Pe3kDa  =  0.009  ±  0.003 
×  10−3  cm/min and 0.010  ±  0.003 ×  10−3  cm/min for 
the pmCPECs grown on filters with 0.4 and 5 μm pores, 
respectively. The permeability coefficient for Lucifer Yel-
low (PeLY) was PeLY = 0.183 ± 0.011 × 10−3 cm/min and 
Pe  =  0.189  ±  0.004  ×  10−3  cm/min for the pmCPECs 
grown on filters with 0.4 and 5  μm pores, respectively. 
Finally, we confirmed comparable growth of contact 
inhibited monolayers of highly pure pmCPECs on the 
inverted sides of filter inserts with 5 and 0.4  μm pores 
by performing immunostainings for claudin-1 (Cldn-1) 
and cytokeratin (CK) (Fig. 7d). In summary, inverted fil-
ter cultures of pmCPEC could successfully be adapted to 
growth on 5 μm pore Transwell filters without impairing 
their barrier characteristics.
Encephalitogenic CD4+ T cells migrate across the BCSFB 
in vitro
Having ensured that barrier characteristics of the mouse 
BCSFB were maintained on 5  μm pore Transwell filters 
we next asked if encephalitogenic T cells could migrate 
from the blood to the CSF side across this pmCPEC mon-
olayer. For this, the pmCPECs were stimulated or not 
with a combination of TNFα and IFNγ. Indeed we found 
that a small percentage of encephalitogenic T cells (3.8 %) 
could cross the non-inflamed pmCPEC monolayer by 
reaching the lower part of the chamber system after 8 h 
of incubation time. Stimulating the pmCPECs with a 
combination of TNFα and IFNγ to inflammation doubled 
T cell migration across the pmCPEC monolayers (8.1 %) 
within the same time (Fig.  8a). In contrast, spontane-
ous migration of encephalitogenic T cells across empty 
filters during that time amounted to almost 70  %. The 
viability of the transmigrated T cells was not impaired 
after crossing the pmCPEC monolayers (Fig.  8b). Simi-
larly, the integrity of the pmCPECs monolayers was not 
affected by T cell diapedesis as confirmed by immuno-
fluorescence staining for junctional molecules like ZO-1 
and claudin-1 and cytokeratin after the 8 h co-incubation 
of T cells with the pmCPEC monolayers (Fig.  8c and 
data not shown). Stimulation of pmCPECs with a com-
bination of TNFα/IFNγ induced increased expression of 
ICAM-1 and VCAM-1 at the protein level (Fig.  8d and 
not shown) suggesting a potential role of these molecules 
in the increased migration of T cells across the TNFα/
IFNγ stimulated pmCPECs compared to non-stimulated 
pmCPECs. Thus, encephalitogenic T cells can migrate 
across our in  vitro model of the BCSFB in the absence 
and presence of inflammatory stimuli. At the same time, 
this in vitro model of the mouse BCSFB provides a bar-
rier for T cell migration and is thus suitable to study the 
mechanisms present at the BCSFB that limit immune cell 
entry into the CNS. Taken together, our in  vitro model 
for the mouse BCSFB constituted of primary mouse 
CPECs in an inverted filter culture is highly suited to 
study the cellular and molecular mechanisms of T cell 
migration across this barrier.
Discussion
There is increasing evidence for an important role of 
the CP in CNS immunity. Comparative transcriptome 
analyses of choroid plexus tissue from healthy mice and 
mice suffering from neuroinflammatory conditions such 
as EAE showed the strongest upregulation of expression 
of genes encoding for adhesion molecules, chemokines 
and cytokines as well as T cell activation markers, sup-
porting a function of the CP in mediating T cell migra-
tion into the CNS [43, 44]. To reach the CSF space at this 
site circulating T cells first have to cross the wall of the 
fenestrated CP microvessels allowing them to reach the 
CP stroma. In a next step they have to migrate across the 
BCSFB established by CP epithelial cells.
To delineate the cellular and molecular mechanisms 
mediating the migration of immune cells across the 
BCSFB from those involved at the BBB, suitable in vitro 
models established from CP epithelial cells are manda-
tory. Especially porcine and rat in  vitro models of the 
BCSFB have been successfully established however only 
a few of these studies have specifically addressed the 
migration of leukocytes across the BCSFB (summarized 
in [45]).
In light of the fact that transgenic approaches ena-
bling the specific manipulation of individual genes have 
advanced in mice and have become an irreplaceable tool 
to analyze gene function in development and pathology, 
mouse models of the BCSFB could significantly improve 
investigations on the potential immune functions of the 
CP. Although a number of laboratories has established 
in  vitro models of the mouse BCSFB [28, 30, 31] these 
models have not been optimized for the in vitro study of 
the immune functions including immune cell migration 
from the periphery into the CNS [8].
Considering the small tissue size of the mouse CP, pri-
mary cultures of CPECs come with the obvious disad-
vantage of the necessity to sacrifice numbers of mice. In 
addition, primary cultures of CPECs have proven to have 
a limited life span of 1–2 weeks and have been reported 
upon passaging to show signs of dedifferentiation, death 
or fibroblast enrichment [14, 22, 29]. However, the low 
turnover rate of primary mouse CPECs can be overcome 
by the addition of growth factors like insulin-like growth 
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factor 1 (IGF-1) and epidermal growth factor (EGF) to 
the culture [31] implying that optimal culture conditions 
of these cells allow for appropriate expansion.
Nevertheless appropriate cell line models for the 
mouse BCSFB would be preferable. Cell lines in general 
bear the advantage of easy handling. They overcome the 
disadvantages of primary cell cultures such as repeated 
necessity to sacrifice significant numbers of mice and 
their short viability as well as their lack of suitability for 
high throughput experiments. Establishing cell lines 
from primary brain endothelial cells has been success-
fully achieved in the past by expression of the polyoma 
middle T oncogene [46] or a temperature-sensitive SV40 
large T followed by expression of the catalytic subunit of 
telomerase [47]. In addition, CP tumors have been used 
to establish CPEC lines. Furthermore, the SV40 large T 
induced rat CPEC line Z310 establishes with a TEER of 
150–200  Ω  cm2 barrier characteristics similar to those 
of primary rat CPECs [22]. At the same time, Z310 cells 
fail to express CPEC specific transporters and junctional 
proteins [48, 49] limiting its suitability for a number of 
research approaches. The slowly proliferating human CP 
papilloma cell line HIBCPP has proven a suitable in vitro 
model for the human BCSFB. If grown under optimized 
conditions, HIBCPP build a permeability barrier reach-
ing a TEER of 200–500  Ω  cm2 and although they only 
Fig. 8 Migration of encephalitogenic CD4+ Th1 cells across the BCSFB in vitro. a Transmigration rates of encephalitogenic CD4+ Th1 effector/mem-
ory T cells across non-stimulated and cytokine-stimulated CPECs during a period of 8 h were assessed in vitro. Percentage of total transmigrated 
encephalitogenic T cells across the unstimulated (−) and TNFα/IFNγ co-stimulated (+) pmCPEC layer in relation to the input sample referred as 
100 %. Data represent mean ± SD of one experiment with three filters per condition. b Viability of T cells in the lower compartment of the Transwell 
filter system was confirmed after the incubation time of 8 h. The error bars represent mean ± SD. c Immunofluorescence staining for the TJ protein 
Claudin 1 (Cldn-1) and for cytokeratin (CK) confirming the intact cellular monolayer integrity after the transmigration assay. d Immunostaining of 
pmCPECs showing upregulation of adhesion molecules ICAM-1 and VCAM-1 upon stimulation with the pro-inflammatory cytokine TNFα. Scale bars 
in c and d = 50 μm
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show a partial contact inhibition, HIBCPP cells express 
the CPEC-specific junctional proteins including clau-
din-11 as observed in vivo [25, 50].
In the present study we have undertaken elaborate 
efforts to establish cell line and primary cell models for 
the mouse BCSFB from different mice that will allow 
study of the immune functions of this barrier includ-
ing the molecular mechanisms mediating the migration 
of immune cells across the BCSFB. Having established 
primary cultures of mouse CPEC we chose to use the 
Immortomouse® as a cellular source for the establish-
ment of CPEC lines. Immortomice® express a tempera-
ture- sensitive mutant of the SV40 large T antigen tsA58, 
which supports cell survival and growth by overcoming 
p53- and pRB-dependent cell cycle arrest, under the con-
trol of the MHC class I promoter. These mice have been 
successfully used to establish epithelial cell lines from 
the gastrointestinal tissues (summarized in [32]), the 
kidney [51] and the mammary gland [33] by expanding 
epithelial cultures under permissive culture conditions, 
namely at 33  °C and in the presence of IFNγ. Re-differ-
entiation of epithelial cells was achieved by growing the 
cells under non-permissive conditions (37 or 39  °C and 
the absence of IFNγ). Taking this experimental approach 
using slight modifications of Whitehead et  al. we suc-
cessfully transformed Immortomouse® derived CPECs 
by growing the cells at 33  °C and the addition of IFNγ 
as reflected by their high proliferation rate over several 
passages which could not be observed under non-per-
missive conditions. However, irrespective of the passage 
tested subsequent withdrawal of IFNγ and culture of the 
Immorto®CPEC lines at 37° or 39° failed to induce epi-
thelial re-differentiation of the cells. Rather, we observed 
in all our Immorto®CPEC lines continuous expression 
of the mesenchymal markers vimentin and N-cadherin 
accompanied by the lack of re-expression of cytokeratin 
and E-cadherin. This suggests that immortalization of 
the Immorto®CPECs induced irreversible and thus SV40 
large T independent epithelial to mesenchymal transition 
(EMT). Spontaneous induction of temperature-sensitive 
growth phenotypes of mouse embryonal fibroblasts, 
independent of a temperature-sensitive immortalizing 
gene, have been observed before [52]. Taken together our 
observations suggest that the Immortomouse® is not well 
suited to establish CPEC lines that can be used to model 
the BCSFB in vitro.
We therefore next analyzed the mouse CP carcinoma 
cell line ECPC4, which was established from a CP car-
cinoma that had developed in transgenic mice express-
ing the SV40 large T antigen [34]. ECPC4 have been 
shown to exhibit a flattened, polygonal morphology and 
to maintain characteristics of CPECs such as expres-
sion of transthyretin (TTR) and α2-macroglobulin when 
originally characterized in passages 13–15. ECPC4 cells 
have subsequently been used to study the activation 
of the kallikrein-kinin system or expression of induc-
ible nitric oxide synthase (iNOS) in the CP in innate 
immunity responses [53, 54] using unknown passages 
of the cells. In the present study, we found that the com-
mercially available ECPC4 from passage 37 and higher, 
despite continued expression of TTR, lacked contact 
inhibition and did not express CPEC specific molecules 
such as cytokeratin or E-cadherin. Rather, all ECPC4 
cells stained positive for vimentin and failed to establish 
CPEC specific junctional complexes. These observa-
tions suggested a significant stage of de-differentiation of 
ECPC4, which was further supported by our observation 
that ECPC4 failed to establish barrier properties such as 
high TEER and low permeability for small soluble trac-
ers. Thus, ECPC4 are not suitable as in  vitro model for 
the mouse BCSFB to study immune functions including 
the migration of T cells across this barrier.
In depth characterization of the primary mouse CPEC 
cultures in the present study demonstrated this approach 
to be a valid in vitro model to study immune functions of 
the mouse BCSFB. Primary mouse CPECs were isolated 
and grown at high purity and formed contact-inhibited 
monolayers. CPECs maintained expression of CPEC spe-
cific molecules and developed mature junctional com-
plexes. Primary mouse CPEC established a tight barrier 
with high trans-epithelial electrical resistance (TEER) 
values comparable to the TEER measured across primary 
CPEC cultures from different species [16, 18–20, 55, 56] 
and across the BCSFB in vivo in cats [57]. Barrier char-
acteristics of our pmCPEC cultures were further con-
firmed by the establishment of a permeability barrier for 
small soluble tracers such as 3 kDa dextran and Lucifer 
Yellow reaching Pe values that are comparable to the Pe 
values measured for the small tracer [14C]Sucrose across 
the BCSFB rat in vitro model [56, 58]. Furthermore, the 
permeability for 3 kDa dextran across the pmCPECs was 
more than fivefold lower than the permeability measured 
across the primary mouse brain microvascular endothe-
lial cells pmBMECs assessed in our laboratory [38] and 
the permeability for Lucifer Yellow was more than two-
fold lower than across the pmBMECs [59] and threefold 
lower than across the novel human BBB model derived 
from hematopoietic stem cells [40].
Taken together cultured pmCPEC maintain important 
barrier characteristics of CPECs in  vivo and are thus a 
suitable model for the mouse BCSFB in vitro.
To study T cell migration across the BCSFB in vitro, the 
pmCPEC cultures were adapted to grow on an inverted 
porous filter membranes as previously described in [37]. 
Interestingly, barrier characteristics of pmCPECs grown 
on the inverted side of the filter were significantly higher 
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than those of pmCPECs grown on the upper side of the 
filter. As we failed to see any visible difference in mor-
phology or in immunostaining of the pmCPEC mon-
olayers, we cannot explain this difference at this time. 
We modelled the migration of encephalitogenic T cells 
across the non-stimulated and stimulated BCSFB in vitro 
and found that in the absence of inflammatory stimuli T 
cells migrated across the pmCPEC monolayer from the 
basolateral to the apical site. Addition of pro-inflamma-
tory cytokines doubled the number of T cells crossing the 
pmCPEC monolayer in the same time—comparable to 
T cell diapedesis observed across a BBB in vitro model, 
respectively [60].
Taken together in the present study, we have success-
fully established an inverted in  vitro filter model of the 
mouse BCSFB with barrier characteristics resembling 
that of the BCSFB in vivo. We provide proof of principle 
that this model is suited to study T cell migration from 
the blood to the CSF side across the BCSFB. This model 
of the mouse BCSFB can be used to investigate whether 
different immune cell subsets can cross the BCSFB and 
enable the cellular and molecular mechanism involved to 
be defined.
Conclusions
A suitable tool for reproducible high throughput inves-
tigations of the molecular and cellular mechanisms that 
mediate the migration of specific immune cells into the 
CNS via the mouse BCSFB is missing to date. Here we 
show that cell line models derived from the Immor-
tomouse® and from the commercially available ECPC4 
are not suited for this purpose. Rather pmCPECs grow-
ing on inverted Transwell filters were defined as a reli-
able in vitro model for experiments mimicking the T cell 
migration from the blood vessel side to the apical side 
facing the CSF. Moreover, our adapted ‘inverted’ BCSFB 
model is suitable for addressing not only the immune cell 
subset extravasation but also the passing of substances 
and pathogens, taking into account the correct orienta-
tion of the polarized cells as it occurs under physiological 
conditions within the brain.
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